Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Lung Cancer

Free Subscription Articles published in Ann Thorac Surg Retrieve available abstracts of 142 articles: HTML format

Single Articles

November 2027
1. TUPPER HI, Shrager JB, Moghanaki D, Simone CB 2nd, et al
   Misinformation and Overestimation of Computed Tomography Lung Cancer Screening Harms - Methodology Matters: A Joint Statement from the Society of Thoracic Surgeons, the American Society for Radiation Oncology, and the American College of Radiology.
   Ann Thorac Surg. 2027 Nov 11:S0003-4975(25)01112.
   PubMed    
   
   
   March 2026
2. WANG S, Zhou Y, Hu S, Bian D, et al
   Neoadjuvant chemoimmunotherapy followed by surgery or radiotherapy for stage IIIA-B non-small cell lung cancer with bulky N2 disease.
   Ann Thorac Surg. 2026 Mar 5:S0003-4975(26)00199.
   PubMed     Abstract available
   
   
   
3. ZHAN PL, Canavan ME, Bader JM, Boffa DJ, et al
   Prolonged Survival in Mesothelioma Patients Without Surgical Resection: A National Cancer Database Analysis.
   Ann Thorac Surg. 2026;121:633-642.
   PubMed     Abstract available
   
   
   February 2026
4. XU W, Li Z, Zheng J, Pan X, et al
   Subsegment-based versus segment-based anatomical sublobar resection for lung cancer: A propensity score-matched analysis.
   Ann Thorac Surg. 2026 Feb 17:S0003-4975(26)00140.
   PubMed     Abstract available
   
   
   
5. MCCRACKEN AL, Antonoff MB
   When Access Is Standardized, Outcomes Converge in Early-Stage Lung Cancer.
   Ann Thorac Surg. 2026 Feb 13:S0003-4975(26)00131.
   PubMed    
   
   
   
6. LIBERMAN M, Jones DR, Wakelee H, Gao S, et al
   Clinical Characteristics and Surgical Outcomes of Patients Receiving Perioperative Pembrolizumab in KEYNOTE-671.
   Ann Thorac Surg. 2026;121:281-289.
   PubMed     Abstract available
   
   
   
7. MURAKAMI J, Tanaka T, Shimokawa M, Yoshimine S, et al
   Probiotic Prophylaxis With Clostridium butyricum for Postoperative Infections Following Lung Resection: A Propensity Score-Weighted Analysis.
   Ann Thorac Surg. 2026;121:459-466.
   PubMed     Abstract available
   
   
   January 2026
8. MUBASHIR M
   Robotic versus Video-Assisted Thoracoscopic Surgery in Non-Small Cell Lung Cancer After Neoadjuvant Therapy: which is superior?!
   Ann Thorac Surg. 2026 Jan 29:S0003-4975(26)00087.
   PubMed    
   
   
   
9. MADEKA I, Koeneman S, Alaparthi S, Grenda T, et al
   Clinical Outcomes in Non-Small Cell Lung Cancer Among Sustained Adopters of Robotic Thoracic Surgery.
   Ann Thorac Surg. 2026 Jan 14:S0003-4975(26)00012.
   PubMed     Abstract available
   
   
   
10. MENG S, Che G
    Segmentectomy vs Lobectomy in non-small cell lung cancer patients with occult lymph node metastasis.
    Ann Thorac Surg. 2026 Jan 10:S0003-4975(26)00006.
    PubMed    
    
    
    December 2025
11. BRANDT WS
    Synchronous Primary Lung Cancer: Sequence of Therapy and Tumor Biology.
    Ann Thorac Surg. 2025 Dec 31:S0003-4975(25)01282.
    PubMed    
    
    
    
12. LI X, Li Q, Zhao E, Yang F, et al
    Perioperative Outcomes of Robotic versus Video-Assisted Thoracoscopic Surgery in Non-Small Cell Lung Cancer After Neoadjuvant Therapy.
    Ann Thorac Surg. 2025 Dec 26:S0003-4975(25)01261.
    PubMed     Abstract available
    
    
    
13. PAN H, Luo Q
    Exploring Prognostic Models and Molecular Mechanisms in Early-Stage Non-Small Cell Lung Cancer with Tumor Spread Through Air Spaces.
    Ann Thorac Surg. 2025 Dec 3:S0003-4975(25)01184.
    PubMed    
    
    
    
14. WILDER FG, Bostock IC, Watkins A, Erfe JM, et al
    Social Determinants of Health in Thoracic Surgery: Critical Points for Understanding and Implementing Change.
    Ann Thorac Surg. 2025;120:1188-1194.
    PubMed     Abstract available
    
    
    November 2025
15. BROWNLEE AR, Perez C, Weiser L, Yu W, et al
    1121 Shape-sensing Robotic-assisted Bronchoscopic Biopsies: Diagnostic Yield and Surgical Implications.
    Ann Thorac Surg. 2025;120:928-936.
    PubMed     Abstract available
    
    
    October 2025
16. NOMURA K, Watanabe T, Takamori S, Hamada A, et al
    Safety Profile of Neoadjuvant Chemoimmunotherapy With Nivolumab for Patients With Resectable Non-Small Cell Lung Cancer in the Real World (CReGYT-04 Neo-Venus).
    Ann Thorac Surg. 2025 Oct 30:S0003-4975(25)01059.
    PubMed     Abstract available
    
    
    
17. SEITLINGER J, Salko O, Bulgarelli Maqueda L, Meng A, et al
    Neoadjuvant chemo-immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography scan predict complete pathological response?
    Ann Thorac Surg. 2025 Oct 28:S0003-4975(25)01054.
    PubMed     Abstract available
    
    
    
18. MOONSAMY P
    Improving Lung Cancer Screening Rates is the Most Important Problem Facing Thoracic Surgeons Today.
    Ann Thorac Surg. 2025 Oct 17:S0003-4975(25)00987.
    PubMed    
    
    
    
19. WANG R, Wang Q, Xu R, Guo W, et al
    Objective Evaluation of Tubeless Thoracic Surgery in Early-stage Lung Cancer Patients Using Multi-modal Digital Device: A Prospective Study.
    Ann Thorac Surg. 2025 Oct 6:S0003-4975(25)00952.
    PubMed     Abstract available
    
    
    
20. PAN H, Tian Y, Chen H, Ge Z, et al
    Lobar versus Sub-Lobar Resection for Clinical Stage IA1-2 Non-Small Cell Lung Cancer with Tumor Spread Through Air Spaces.
    Ann Thorac Surg. 2025 Oct 4:S0003-4975(25)00909.
    PubMed     Abstract available
    
    
    
21. LEE J, Hong YS, Lee J, Lee G, et al
    Clinical N Staging Subclassification for Stage III-N2 NSCLC Patients Undergoing Trimodality Therapy: A Good Beginning Is Half the Battle.
    Ann Thorac Surg. 2025;120:665-673.
    PubMed     Abstract available
    
    
    September 2025
22. HINES SE, Dement J, Ringen K
    Occupational Risk: A Gap in Lung Cancer Screening Guidelines.
    Ann Thorac Surg. 2025 Sep 30:S0003-4975(25)00903.
    PubMed    
    
    
    
23. QU R, Fu X
    Occult N1 Non-Small Cell Lung Cancer: Why We Need Caution Before Embracing Segmentectomy as Standard.
    Ann Thorac Surg. 2025 Sep 30:S0003-4975(25)00905.
    PubMed    
    
    
    
24. WAGEMAKER VIANA S, Van Haren RM
    Bridging the Gap in Lung Cancer Screening: Lessons from a Culturally Tailored Intervention with Lay Navigators.
    Ann Thorac Surg. 2025 Sep 19:S0003-4975(25)00886.
    PubMed    
    
    
    
25. SERVAIS EL
    Defining Success in Synchronous Primary Early Lung Cancer: Recurrence Matters.
    Ann Thorac Surg. 2025 Sep 5:S0003-4975(25)00855.
    PubMed    
    
    
    
26. BRANDT WS, Rossetti NE, Eaton DB, Samson P, et al
    Synchronous Primary Early-Stage Non-Small Cell Lung Cancer: Trends in Management and Factors Associated with Improved Survival.
    Ann Thorac Surg. 2025 Sep 2:S0003-4975(25)00843.
    PubMed     Abstract available
    
    
    
27. MOTT NM, Meguid RA, Fendrick AM
    Securing Lung Cancer Screening, The First Step.
    Ann Thorac Surg. 2025 Sep 2:S0003-4975(25)00836.
    PubMed    
    
    
    August 2025
28. SEYOUM N, Eaton DB Jr, Tohmasi S, Rossetti N, et al
    Adherence to Post-Operative Survivorship Quality Metrics in Early-Stage Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2025 Aug 27:S0003-4975(25)00797.
    PubMed     Abstract available
    
    
    
29. VELOTTA JB, Burapachaisri K, Baskin AS, Zhu Z, et al
    The Importance of Lay Navigators in Lung Cancer Screening Among Asian Americans in an Integrated Healthcare System.
    Ann Thorac Surg. 2025 Aug 20:S0003-4975(25)00761.
    PubMed     Abstract available
    
    
    
30. GRIFFITH A, Pratt CG, Whitrock JN, Moore AN, et al
    Achieving Equitable Care for Racial Minority Patients with a Lung Cancer Screening Program.
    Ann Thorac Surg. 2025 Aug 12:S0003-4975(25)00749.
    PubMed     Abstract available
    
    
    
31. EZENWANKWO E
    Securing CT Lung Cancer Screening Access: Implications of the Supreme Court's Ruling in Kennedy v. Braidwood.
    Ann Thorac Surg. 2025 Aug 12:S0003-4975(25)00755.
    PubMed    
    
    
    
32. ABDALLAT M, Leo RT, Sugarbaker EA, McAllister M, et al
    Segmentectomy vs Lobectomy for Occult N1 in Non-Small Cell Lung Cancer: Is Less Still More?
    Ann Thorac Surg. 2025 Aug 8:S0003-4975(25)00725.
    PubMed     Abstract available
    
    
    
33. NG AP, Sanaiha Y, Hadaya JE, Verma A, et al
    Risk of Financial Toxicity Among Adults Undergoing Lung and Esophageal Resections for Cancer.
    Ann Thorac Surg. 2025;120:283-292.
    PubMed     Abstract available
    
    
    July 2025
34. TUPPER HI, Mendelson DS, Doo FX, Carlos RC, et al
    Imaging Interoperability: #DitchtheDisk is a Health Equity Imperative for Lung Cancer Screening & Beyond.
    Ann Thorac Surg. 2025 Jul 19:S0003-4975(25)00662.
    PubMed    
    
    
    
35. RYUKO T, Okazaki M, Mitsuhashi T, Suzawa K, et al
    Comparable Clinical Outcomes Between Segmentectomy and Lobectomy for NSCLC With Unsuspected N1/N2: A Multicenter Real-World Data Study.
    Ann Thorac Surg. 2025;120:87-98.
    PubMed     Abstract available
    
    
    
36. WEN J, Chen T, Li Y, Dong Y, et al
    Comparison of Short- and Long-term Outcomes in Patients Undergoing Sleeve Lobectomy With or Without Buttressing the Bronchial Anastomosis.
    Ann Thorac Surg. 2025;120:100-107.
    PubMed     Abstract available
    
    
    
37. OPITZ I, Lauk O, Werner R, Matter A, et al
    Characteristics of Long-term Survivors With Malignant Pleural Mesothelioma.
    Ann Thorac Surg. 2025;120:108-116.
    PubMed     Abstract available
    
    
    June 2025
38. KITAZAWA S, Bernards N, Sata Y, Yokote F, et al
    INTRAOPERATIVE SURGICAL MARGIN ASSESSMENT OF SUBLOBAR LUNG RESECTION SPECIMENS USING COMPUTED TOMOGRAPHY.
    Ann Thorac Surg. 2025 Jun 23:S0003-4975(25)00546.
    PubMed     Abstract available
    
    
    
39. HURR R, Potter AL, Jeffrey Yang CF
    Improving Lung Cancer Screening Uptake Takes a Village: The Power of Partnering with High Catchment Hospital Departments.
    Ann Thorac Surg. 2025 Jun 18:S0003-4975(25)00532.
    PubMed    
    
    
    
40. WEN J, Dong Y, Chen T, Wu J, et al
    Prognostic Impact and Recurrence Pattern of KRAS G12C Mutation in Surgically Resected Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2025 Jun 16:S0003-4975(25)00526.
    PubMed     Abstract available
    
    
    
41. RATHORE K
    Globally Recognised Difficulties in Lung Cancer Care Management That May Lead to Poor Outcomes.
    Ann Thorac Surg. 2025 Jun 16:S0003-4975(25)00527.
    PubMed    
    
    
    
42. TOMPKINS AK, Azuma M, Erkmen CP
    From Broadening to Optimizing: Refining Approach to Lung Cancer Screening Criteria.
    Ann Thorac Surg. 2025 Jun 13:S0003-4975(25)00518.
    PubMed    
    
    
    
43. REDDINGTON H, Emmerick I, Crawford A, Briskin C, et al
    Safety and Efficacy of Oncologic Second Pulmonary Resections: A Study of the Society of Thoracic Surgeons General Thoracic Surgery Database.
    Ann Thorac Surg. 2025 Jun 5:S0003-4975(25)00488.
    PubMed     Abstract available
    
    
    
44. XIE S, Hu Q, Wu Z, Wang B, et al
    Clinical and Genetic Characteristics of Early-Onset Lung Adenocarcinoma in a Large Chinese Cohort.
    Ann Thorac Surg. 2025;119:1196-1204.
    PubMed     Abstract available
    
    
    May 2025
45. WU VS, Boutros C, Bassiri A, Jiang B, et al
    Reassessing Efficacy: Understanding Failures in Lung Cancer Screening Despite Low-Dose CT Protocol Adherence.
    Ann Thorac Surg. 2025 May 28:S0003-4975(25)00448.
    PubMed     Abstract available
    
    
    
46. KHAN AA, Shah SK, Adebayo OW, Brooks C, et al
    Association Between Surgical Start Time and Major Morbidity or Mortality after Pulmonary Resection.
    Ann Thorac Surg. 2025 May 28:S0003-4975(25)00446.
    PubMed     Abstract available
    
    
    
47. LIANG H, Wang W, Zhang M, Wang R, et al
    Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer.
    Ann Thorac Surg. 2025 May 15:S0003-4975(25)00420.
    PubMed     Abstract available
    
    
    
48. KALTMAN M, Yalamanchili S, Park JA, Weyant MJ, et al
    High catchment areas for lung cancer screening-eligible patients.
    Ann Thorac Surg. 2025 May 13:S0003-4975(25)00414.
    PubMed     Abstract available
    
    
    
49. DING H, Tao B, Xu L, Jiang G, et al
    Neoadjuvant Immunochemotherapy for Stage II-IIIB Non-Small Cell Lung Cancer with Mutations Beyond EGFR 19del, L858R, and ALK rearrangement.
    Ann Thorac Surg. 2025 May 6:S0003-4975(25)00378.
    PubMed     Abstract available
    
    
    
50. KHAN AA, Shah SK, Naeem W, Ansari M, et al
    Association Between Social Vulnerability Index and Time-to-Treatment in Resectable Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2025 May 6:S0003-4975(25)00380.
    PubMed     Abstract available
    
    
    
51. LAM GT
    Medicaid Expansion and Regionalization of Lung Cancer Surgery: A Double-Edged Sword?
    Ann Thorac Surg. 2025 May 2:S0003-4975(25)00374.
    PubMed    
    
    
    
52. WOODARD GA, Grau-Sepulveda M, Onaitis MW, Udelsman BV, et al
    Lobectomy vs Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation.
    Ann Thorac Surg. 2025;119:1071-1081.
    PubMed     Abstract available
    
    
    April 2025
53. ORTIZ BA, Engrav SK, Roden AC, Boland JM, et al
    Impact of frozen section pathology examination of surgical margins in sublobar pulmonary resections for clinical stage IA NSCLC.
    Ann Thorac Surg. 2025 Apr 25:S0003-4975(25)00338.
    PubMed     Abstract available
    
    
    
54. HOODA Z, Duan Z, Ries S, Antonoff MB, et al
    Association of Medicaid Expansion With Timely Treatment and Access to High-Volume Hospitals in Early-Stage Lung Cancer Patients.
    Ann Thorac Surg. 2025 Apr 11:S0003-4975(25)00321.
    PubMed     Abstract available
    
    
    
55. CHEN J, Zhao ZR, Deng H, Yang C, et al
    Extended sleeve lobectomy after neoadjuvant immunochemotherapy for centrally located non-small cell lung cancer.
    Ann Thorac Surg. 2025 Apr 9:S0003-4975(25)00298.
    PubMed     Abstract available
    
    
    
56. VANWINKLE CK, Fu W, Hassett KP, Thompson MP, et al
    The Association between Participation in a Quality Collaborative and Value in Lung Cancer Surgery.
    Ann Thorac Surg. 2025 Apr 5:S0003-4975(25)00295.
    PubMed     Abstract available
    
    
    
57. RUSCH VW
    An unresolved surgical conundrum: How to manage unsuspected nodal involvement in early-stage lung cancer.
    Ann Thorac Surg. 2025 Apr 2:S0003-4975(25)00282.
    PubMed    
    
    
    March 2025
58. SHAH SK, Khan AA, Basu S, Seder CW, et al
    Minimally Invasive Pneumonectomy vs Open Pneumonectomy: Outcomes and Predictors of Conversion.
    Ann Thorac Surg. 2025;119:634-642.
    PubMed     Abstract available
    
    
    
59. EISENBERG M, Deboever N, Hofstetter WL, Mehran RJ, et al
    Pulmonary Surgical Margins for Metastatic Osteosarcoma: Is Negative Margin Enough?
    Ann Thorac Surg. 2025;119:616-624.
    PubMed     Abstract available
    
    
    February 2025
60. VERGE R, Rouch A, Rabinel P, Renaud C, et al
    Evaluation of uncertain resection for localized non-small cell lung cancer: the crucial prognosis of suboptimal lymph node assessment.
    Ann Thorac Surg. 2025 Feb 27:S0003-4975(25)00170.
    PubMed     Abstract available
    
    
    
61. FARINA JM, D'Cunha J
    Sorting Out the Pieces of Fragmented Lung Cancer Care.
    Ann Thorac Surg. 2025 Feb 19:S0003-4975(25)00120.
    PubMed    
    
    
    
62. CROSINA J, Wright F, Irish J, Rashid M, et al
    Long-Term Impact of Regionalization of Thoracic Oncology Surgery.
    Ann Thorac Surg. 2025;119:460-469.
    PubMed     Abstract available
    
    
    
63. RESIO BJ, Tan KS, Skovgard M, Dycoco J, et al
    Commission on Cancer Standards for Lymph Node Sampling and Oncologic Outcomes After Lung Resection.
    Ann Thorac Surg. 2025;119:308-315.
    PubMed     Abstract available
    
    
    
64. HUANG L, Petersen RH
    Impact of Margin Distance on Locoregional Recurrence and Survival After Thoracoscopic Segmentectomy.
    Ann Thorac Surg. 2025;119:316-324.
    PubMed     Abstract available
    
    
    
65. HAYANGA JWA, Luo X, Hasasna I, Rothenberg P, et al
    Intersection of Race, Rurality, and Income in Defining Access to Minimally Invasive Lung Surgery.
    Ann Thorac Surg. 2025;119:325-332.
    PubMed     Abstract available
    
    
    January 2025
66. KAMTAM DN, Berry MF, Lin N, Kapula N, et al
    The association of chylothorax with aggressiveness of lymph node management during pulmonary resection.
    Ann Thorac Surg. 2025 Jan 31:S0003-4975(25)00086.
    PubMed     Abstract available
    
    
    
67. POTTER AL, Guo Q, Srinivasan D, Yang ME, et al
    Assessing Lung Cancer Screening Eligibility of Lung Cancer Patients in the Boston Lung Cancer Study: An Analysis of 7,186 Lung Cancer Cases.
    Ann Thorac Surg. 2025 Jan 21:S0003-4975(25)00067.
    PubMed     Abstract available
    
    
    
68. ANTONOFF MB, Mitchell KG, Kim SS, Salfity HV, et al
    The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer.
    Ann Thorac Surg. 2025 Jan 9:S0003-4975(24)00960.
    PubMed     Abstract available
    
    
    
69. KRANTZ SB, Mitzman B, Antonoff MB, Backhus L, et al
    Thoracic Surgery Outcomes Research Network (ThORN) Consensus Document on Defining a High Quality Wedge Resection for Early Stage Lung Cancer.
    Ann Thorac Surg. 2025 Jan 8:S0003-4975(25)00004.
    PubMed     Abstract available
    
    
    
70. MIMAE T, Miyata Y, Tsubokawa N, Kudo Y, et al
    Omitting Lymph Node Dissection for Small Ground-Glass Opacity-Dominant Tumors.
    Ann Thorac Surg. 2025;119:192-198.
    PubMed     Abstract available
    
    
    December 2024
71. STUART CM, Mott NM, Bronsert MR, Randhawa SK, et al
    The Association between Sociodemographic Factors and Delays to Minimally Invasive Surgery for Stage IA-IIIA Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Dec 24:S0003-4975(24)01115.
    PubMed     Abstract available
    
    
    
72. MATSUDO K, Takada K, Kinoshita F, Hashinokuchi A, et al
    CD155 Expression in Early-Stage Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;118:1197-1205.
    PubMed     Abstract available
    
    
    November 2024
73. HOODA Z, Antonoff MB
    Using Lung Cancer Screening To Treat the Whole Patient, Not the Disease.
    Ann Thorac Surg. 2024 Nov 27:S0003-4975(24)01017.
    PubMed    
    
    
    
74. AL-THANI S, Nasar A, Villena-Vargas J, Chow O, et al
    Does High Standard Uptake Value on Positron Emission Tomography Preclude Sublobar Resection in Stage IA Non-Small Cell Lung Cancer
    Ann Thorac Surg. 2024 Nov 13:S0003-4975(24)00957.
    PubMed     Abstract available
    
    
    
75. ODEH A, Verm R, Park S, Swanson J, et al
    Fragmented care, Commission on Cancer Accreditation and Overall Survival in Patients Receiving Surgery and Chemotherapy for Lung Cancer.
    Ann Thorac Surg. 2024 Nov 11:S0003-4975(24)00940.
    PubMed     Abstract available
    
    
    
76. LANUTI M
    What Is Best Liquid Remnant for Resected Early-Stage Non-small Cell Lung Cancer?
    Ann Thorac Surg. 2024;118:1144-1145.
    PubMed    
    
    
    October 2024
77. ELY S, Osarogiagbon RU
    Metrics for Benchmarking Lung Cancer Surgery Quality: Not waiting for Godot!
    Ann Thorac Surg. 2024 Oct 29:S0003-4975(24)00924.
    PubMed    
    
    
    
78. HOODA Z, Antonoff MB
    Less is More-Further Evidence Favoring Segmentectomy for Clinical Stage IA Lung Cancer.
    Ann Thorac Surg. 2024 Oct 25:S0003-4975(24)00882.
    PubMed    
    
    
    
79. LI Z, Wu L, Wang C, Wang S, et al
    Outcomes after neoadjuvant therapy with/without immunotherapy followed by pneumonectomy in non-small cell lung cancer patients.
    Ann Thorac Surg. 2024 Oct 25:S0003-4975(24)00879.
    PubMed     Abstract available
    
    
    
80. D'ANDRILLI A, Marinucci BT, Ciccone AM, Ibrahim M, et al
    CARINAL RECONSTRUCTION FOR LUNG CANCER AND AIRWAY TUMORS: LONG-TERM RESULTS.
    Ann Thorac Surg. 2024 Oct 22:S0003-4975(24)00876.
    PubMed     Abstract available
    
    
    
81. RICE D, Singhal S, Niemeyer E, Sarkaria I, et al
    Intraoperative Molecular Imaging with Pafolacianine in Resection of Occult Pulmonary Malignancy in the ELUCIDATE trial.
    Ann Thorac Surg. 2024 Oct 21:S0003-4975(24)00869.
    PubMed     Abstract available
    
    
    
82. LI X, Li Q, Yang F, Gao E, et al
    Survival Outcomes of Neoadjuvant Therapy Followed by Sleeve Lobectomy in Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Oct 17:S0003-4975(24)00863.
    PubMed     Abstract available
    
    
    
83. KIM SS, Cooke DT, Kidane B, Tapias LF, et al
    The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Oct 16:S0003-4975(24)00861.
    PubMed     Abstract available
    
    
    
84. RUSCH VW
    Sublobar Resection for Subsolid Lung Adenocarcinomas: How Much Margin Is Enough?
    Ann Thorac Surg. 2024;118:810.
    PubMed    
    
    
    
85. GROTH SS
    Unraveling the Association Between Size of Lepidic-Predominant Adenocarcinomas and the Risk of Nodal Metastasis.
    Ann Thorac Surg. 2024;118:823-824.
    PubMed    
    
    
    
86. KAMTAM DN, Berry MF, Lui NS, Satoyoshi M, et al
    What Is an Adequate Margin During Sublobar Resection of
    Ann Thorac Surg. 2024;118:801-809.
    PubMed     Abstract available
    
    
    
87. SI H, Xu L, Zhao Y, Su H, et al
    Spread Through Air Spaces in Residual Tumor Classification for Clinical IA Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;118:825-833.
    PubMed     Abstract available
    
    
    
88. WONG LY, Elliott IA, Liou DZ, Backhus LM, et al
    Lepidic-Type Lung Adenocarcinomas: Is It Safe to Observe for Growth Before Treating?
    Ann Thorac Surg. 2024;118:817-823.
    PubMed     Abstract available
    
    
    September 2024
89. XU R, Miao P
    Public health and social work collaborative rehabilitation assessment of different lung cancer resection.
    Ann Thorac Surg. 2024 Sep 20:S0003-4975(24)00825.
    PubMed    
    
    
    
90. BROWNLEE AR
    When a Lung Nodule Program Becomes Self-Aware.
    Ann Thorac Surg. 2024;118:718-719.
    PubMed    
    
    
    
91. KRANTZ SB, Su KW
    More for More's Sake Alone? Completion Lobectomy in the Setting of Occult Nodal Disease.
    Ann Thorac Surg. 2024;118:663-664.
    PubMed    
    
    
    
92. HEADRICK JR JR, Parker MJ, Miller AD
    Artificial Intelligence: Can It Save Lives, Hospitals, and Lung Screening?
    Ann Thorac Surg. 2024;118:712-718.
    PubMed     Abstract available
    
    
    
93. KNEUERTZ PJ
    Real-World Experience Favors a Neoadjuvant Strategy of Chemoimmunotherapy for Locoregionally Advanced NSCLC.
    Ann Thorac Surg. 2024;118:681-682.
    PubMed    
    
    
    
94. MARTIN JL, Mack SJ, Rshaidat H, Collins ML, et al
    Wedge Resection Outcomes: A Comparison of Video-Assisted and Robot-Assisted Wedge Resections.
    Ann Thorac Surg. 2024;118:683-690.
    PubMed     Abstract available
    
    
    August 2024
95. BROWN LM, Bonnell L, Parsons N, Cooke DT, et al
    Predictors of Discharge with Supplemental Oxygen after Lobectomy for Lung Cancer.
    Ann Thorac Surg. 2024 Aug 28:S0003-4975(24)00693.
    PubMed     Abstract available
    
    
    
96. MCALLISTER MA, Herrera-Zamora J, Barcelos RR, Leo R, et al
    Left Upper Lobectomy versus Trisegmentectomy for Lung Cancer: A Propensity-Score Matched Comparison.
    Ann Thorac Surg. 2024 Aug 26:S0003-4975(24)00684.
    PubMed     Abstract available
    
    
    
97. TONG BC, Bonnell LN, Habib RH, Shahian DM, et al
    The STS 2024 Risk Models for Lung Cancer Resection: Continued Refinement and Improved Outcomes.
    Ann Thorac Surg. 2024 Aug 26:S0003-4975(24)00686.
    PubMed     Abstract available
    
    
    
98. ROSSETTI NE, Eaton DB Jr, Tohmasi S, Heiden BT, et al
    Early-stage lung cancer in the era of lung cancer screening: VA outperforms other insurance models.
    Ann Thorac Surg. 2024 Aug 21:S0003-4975(24)00678.
    PubMed     Abstract available
    
    
    
99. MITZMAN B
    The Entire NSCLC Spectrum: No Cancer Left Behind.
    Ann Thorac Surg. 2024;118:393-394.
    PubMed    
    
    
    
100. DAI J, Sun F, Bao M, Cao J, et al
     Pulmonary Function Recovery and Displacement Patterns After Anatomic Segmentectomy vs Lobectomy.
     Ann Thorac Surg. 2024;118:365-374.
     PubMed     Abstract available
     
     
     
101. CAMPISI A, Dell'Amore A, Faccioli E, Fang W, et al
     A Multicenter Retrospective Case-Control Study on Simple vs Extended Sleeve Lobectomies.
     Ann Thorac Surg. 2024;118:375-383.
     PubMed     Abstract available
     
     
     
102. WAN S, Shen Z, Hu S, Zhang L, et al
     Spread Through Air Spaces in Stage I Pulmonary Large Cell Neuroendocrine Carcinoma.
     Ann Thorac Surg. 2024;118:385-393.
     PubMed     Abstract available
     
     
     July 2024
103. RUSCH VW
     Surgical Resection for Pleural Mesothelioma: Is It All About Patient Selection?
     Ann Thorac Surg. 2024;118:223-224.
     PubMed    
     
     
     
104. NAKAMURA A, Hashimoto M, Kuroda A, Matsumoto S, et al
     Impact of Operation on Disease Progression and Survival of Patients With Pleural Mesothelioma.
     Ann Thorac Surg. 2024;118:216-223.
     PubMed     Abstract available
     
     
     
105. KAGIMOTO A, Ishida M, Mimura T
     Significance of the Goddard Score in Predicting Complications Related to Air Leak After Lobectomy.
     Ann Thorac Surg. 2024;118:233-239.
     PubMed     Abstract available
     
     
     June 2024
106. WONG LY, Dale R, Kapula N, Elliott IA, et al
     Impacts of Positive Margins and Surgical Extent on Outcomes after Early-Stage Lung Cancer Resection.
     Ann Thorac Surg. 2024 Jun 10:S0003-4975(24)00460.
     PubMed     Abstract available
     
     
     
107. NOBEL TB, Tan KS, Adusumilli PS, Bains MS, et al
     Outcomes of Patients Undergoing Segmentectomy for Occult Node-Positive Clinical Stage IA Lung Cancer.
     Ann Thorac Surg. 2024 Jun 10:S0003-4975(24)00448.
     PubMed     Abstract available
     
     
     
108. BRIBRIESCO A
     Aim Local, Expect Global-EGFR and Recurrence in Stage I Lung Adenocarcinoma.
     Ann Thorac Surg. 2024;117:1119-1120.
     PubMed    
     
     
     
109. YANG F, Sun K, Li F, Li X, et al
     The Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Clinical Stage I Lung Adenocarcinoma.
     Ann Thorac Surg. 2024;117:1111-1119.
     PubMed     Abstract available
     
     
     May 2024
110. BOU-SAMRA P, Kennedy GT, Chang A, Guo E, et al
     Phase 2 Trial of VGT-309: Cathepsin-Based Near-Infrared Probe for Intraoperative Molecular Imaging.
     Ann Thorac Surg. 2024 May 30:S0003-4975(24)00396.
     PubMed     Abstract available
     
     
     
111. SAWABATA N, Hamaji M, Yoshikawa D, Miyata R, et al
     Clustered circulating tumor cells as a predictor of adjuvant-chemotherapy efficacy in lung cancer.
     Ann Thorac Surg. 2024 May 22:S0003-4975(24)00379.
     PubMed     Abstract available
     
     
     
112. RUSCH VW
     Wedge Resection Versus Segmentectomy for Clinical Stage IA Non-small Cell Lung Cancer: Are They Truly Oncologically Equivalent?
     Ann Thorac Surg. 2024 May 9:S0003-4975(24)00359.
     PubMed    
     
     
     April 2024
113. TAKAHASHI T
     Study-design of adjuvant chemotherapy for lung cancer: A cart before the horse.
     Ann Thorac Surg. 2024 Apr 13:S0003-4975(24)00285.
     PubMed    
     
     
     
114. SHAHZAD MH, Spicer JD, Rusch VW, Kneuertz PJ, et al
     Perioperative Immunotherapy for Node-Negative Non-Small Cell Lung Cancer - Current Evidence and Future Directions.
     Ann Thorac Surg. 2024 Apr 13:S0003-4975(24)00280.
     PubMed     Abstract available
     
     
     
115. BLASBERG JD, Li A
     Evening the Odds: Making 1 + 1 = 2 for Bilobectomy.
     Ann Thorac Surg. 2024;117:874-875.
     PubMed    
     
     
     
116. KAMIGAICHI A, Mimae T, Tsubokawa N, Miyata Y, et al
     Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma.
     Ann Thorac Surg. 2024;117:743-751.
     PubMed     Abstract available
     
     
     March 2024
117. TOWE CW, Grau-Sepulveda MV, Hartwig MG, Kang L, et al
     STS Database Analysis: Comparing Sublobar Techniques in Stage IA Lung Cancer.
     Ann Thorac Surg. 2024 Mar 15:S0003-4975(24)00191.
     PubMed     Abstract available
     
     
     
118. FERRARIS VA
     Venous Thromboembolism as Postoperative Complication Following Lung Cancer Operations.
     Ann Thorac Surg. 2024 Mar 15:S0003-4975(24)00188.
     PubMed    
     
     
     
119. STILES BM, Rodriguez-Quintero JH
     A "Solid" Rationale for Lymphadenectomy in Small, Peripheral Lung Cancers.
     Ann Thorac Surg. 2024;117:593.
     PubMed    
     
     
     February 2024
120. ALDERETE IS, Nakata K, Hartwig MG
     Overcoming Hesitancy: Embracing Extended Sleeve Lobectomy for Advanced Non-Small Cell Lung Cancer.
     Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00120.
     PubMed    
     
     
     
121. PONTULA A, Spies CS, Hartwig MG
     Incidentally Found Lung Cancer Following Lung Transplantation: Apples and Oranges.
     Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00118.
     PubMed    
     
     
     
122. DUNNE EG, Fick CN, Isbell JM, Chaft JE, et al
     The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.
     Ann Thorac Surg. 2024 Feb 3:S0003-4975(24)00080.
     PubMed     Abstract available
     
     
     
123. YOUNG AM, Viktorsson SA, Strobel RJ, Rotar EP, et al
     Five-Year Sustained Impact of a Thoracic Enhanced Recovery After Surgery Program.
     Ann Thorac Surg. 2024;117:422-430.
     PubMed     Abstract available
     
     
     
124. FERRARI-LIGHT D, Kneuertz PJ
     Life in the Fast Lane: Rapid Discharge After Minimally Invasive Anatomic Lung Resection Is Feasible and Safe.
     Ann Thorac Surg. 2024;117:303-304.
     PubMed    
     
     
     January 2024
125. COSTER JN, Sanchez PG
     Surviving Incidentally Found Non-Small Cell Lung Cancer After Lung Transplantation.
     Ann Thorac Surg. 2024 Jan 27:S0003-4975(24)00071.
     PubMed    
     
     
     
126. FONG AJ, Reich H, Mirocha J, Wong A, et al
     Disparities and Underutilization of Surgery for Early Stage Small Cell Lung Cancer.
     Ann Thorac Surg. 2024 Jan 26:S0003-4975(24)00067.
     PubMed     Abstract available
     
     
     
127. AXTELL AL, Gaissert HA, Bao X, Auchincloss HG, et al
     Predictors of Venous Thromboembolism after Lung Cancer Resection.
     Ann Thorac Surg. 2024 Jan 25:S0003-4975(24)00014.
     PubMed     Abstract available
     
     
     
128. MARTINS RS, Razi SS, Alnajar A, Poulikidis K, et al
     Neoadjuvant versus Adjuvant Chemoimmunotherapy for Stage II-IIIB Non-Small Cell Lung Cancer.
     Ann Thorac Surg. 2024 Jan 19:S0003-4975(24)00013.
     PubMed     Abstract available
     
     
     
129. POTTER AL, Senthil P, Keshwani A, McCleery S, et al
     Long-term Survival After Lung Cancer Resection in the National Lung Screening Trial.
     Ann Thorac Surg. 2024 Jan 10:S0003-4975(24)00004.
     PubMed     Abstract available
     
     
     
130. MIMAE T, Miyata Y, Tsubokawa N, Shimada Y, et al
     Sublobar resection in early non-small cell lung cancer with epidermal growth factor receptor mutant.
     Ann Thorac Surg. 2024 Jan 8:S0003-4975(24)00002.
     PubMed     Abstract available
     
     
     
131. KNEUERTZ PJ, Ferrari-Light D, Altorki NK
     Sublobar Resection vs Lobectomy for Stage IA Non-Small Cell Lung Carcinoma-Takeaways From Modern Randomized Trials.
     Ann Thorac Surg. 2024 Jan 5:S0003-4975(24)00001.
     PubMed     Abstract available
     
     
     
132. LI AX, Canavan ME, Ermer T, Maduka RC, et al
     Respect the Middle Lobe: Perioperative Risk of Bilobectomy Compared With Lobectomy and Pneumonectomy.
     Ann Thorac Surg. 2024;117:163-171.
     PubMed     Abstract available
     
     
     November 2023
133. COLLINS ML, Mack SJ, Whitehorn GL, Till BM, et al
     Access to Guideline Concordant Care for Node-Positive Non-Small Cell Lung Cancer in the United States.
     Ann Thorac Surg. 2023 Nov 21:S0003-4975(23)01165.
     PubMed     Abstract available
     
     
     
134. YUN T, Zhang Y, Liu A, Qin Y, et al
     Randomized Trial of Modified Chest Tube Placement vs Routine Placement After Lung Resection.
     Ann Thorac Surg. 2023;116:1013-1019.
     PubMed     Abstract available
     
     
     
135. ROSENSTEIN AL, Potter AL, Senthil P, Raman V, et al
     The Role of Salvage Resection After Definitive Radiation Therapy for Non-small Cell Lung Cancer.
     Ann Thorac Surg. 2023;116:997-1003.
     PubMed     Abstract available
     
     
     
136. ZHOU N, Niu J, Nelson D, Feldman HA, et al
     Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection.
     Ann Thorac Surg. 2023;116:1020-1027.
     PubMed     Abstract available
     
     
     October 2023
137. MORKVED AL, Sogaard M, Skjoth F, Ording AG, et al
     Risk and timing of venous thromboembolism after surgery for lung cancer: a nationwide cohort study.
     Ann Thorac Surg. 2023 Oct 25:S0003-4975(23)01073.
     PubMed     Abstract available
     
     
     
138. RSHAIDAT H, Okusanya OT
     Using the Ultimate Lung Biopsy.
     Ann Thorac Surg. 2023;116:701-702.
     PubMed    
     
     
     September 2023
139. RUSCH VW
     Process improvement in lymphadenectomy for lung cancer: The wave of the future?
     Ann Thorac Surg. 2023 Sep 15:S0003-4975(23)00958.
     PubMed    
     
     
     
140. SPIES CS, Ochoa TN, Pontula A, Harris CS, et al
     With Comparable Outcomes, Should Early Stage Lung Cancer Be A Contraindication to Lung Transplant?
     Ann Thorac Surg. 2023 Sep 11:S0003-4975(23)00934.
     PubMed     Abstract available
     
     
     
141. OSAROGIAGBON RU, Ray MA, Fehnel C, Akinbobola O, et al
     Two Interventions on Pathologic Nodal Staging in a Population-Based Lung Cancer Resection Cohort.
     Ann Thorac Surg. 2023 Sep 5:S0003-4975(23)00927.
     PubMed     Abstract available
     
     
     August 2023
142. POTTER AL, Spasojevic A, Raman V, Hurd JC, et al
     The Increasing Adoption of Minimally Invasive Lobectomy in the United States.
     Ann Thorac Surg. 2023;116:222-229.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum